ReviewBritish journal of clinical pharmacology2007
Clinical risk management of herb-drug interactions.
Review in British journal of clinical pharmacology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Interactions between herbal medicines and prescribed drugs: an updated systematic review.Drugs · 2009Pooled it
- Drug-herb interactions: a challenge and clinical concern in primary healthcare.Frontiers in medicine · 2025Review
- BABINE: An original and user-friendly scale for the simple and quick management of herb-drug interactions in clinical practice.BMC complementary medicine and therapies · 2024Article
- Safety Concerns Related to the Simultaneous Use of Prescription or Over-the-Counter Medications and Herbal Medicinal Products: Survey Results among Latvian Citizens.International journal of environmental research and public health · 2023Article
- Expanding potential targets of herbal chemicals by node2vec based on herb-drug interactions.Chinese medicine · 2023Article
- Herb-anticancer drug interactions in real life based on VigiBase, the WHO global database.Scientific reports · 2022Article
- An Overview of the Evidence and Mechanism of Drug-Herb Interactions Between Propolis and Pharmaceutical Drugs.Frontiers in pharmacology · 2022Review
- Negligible Effect of Quercetin in the Pharmacokinetics of Sulfasalazine in Rats and Beagles: Metabolic Inactivation of the Interaction Potential of Quercetin with BCRP.Pharmaceutics · 2021Article
- Multifaceted Factors Causing Conflicting Outcomes in Herb-Drug Interactions.Pharmaceutics · 2020Review
- Herb-drug interactions: a novel algorithm-assisted information system for pharmacokinetic drug interactions with herbal supplements in cancer treatment.European journal of clinical pharmacology · 2019Article
- Pretreatment of Shaoyao Gancao Decoction () alters pharmacokinetics of intravenous paclitaxel in rats.Chinese journal of integrative medicine · 2017Article
- Nerolidol: A Sesquiterpene Alcohol with Multi-Faceted Pharmacological and Biological Activities.Molecules (Basel, Switzerland) · 2016Review
- In vitro Effects of Four Native Brazilian Medicinal Plants in CYP3A4 mRNA Gene Expression, Glutathione Levels, and P-Glycoprotein Activity.Frontiers in pharmacology · 2016Article
- Quality and safety of herbal medical products: regulation and the need for quality assurance along the value chains.British journal of clinical pharmacology · 2015Review
- Estimation of the binding modes with important human cytochrome P450 enzymes, drug interaction potential, pharmacokinetics, and hepatotoxicity of ginger components using molecular docking, computational, and pharmacokinetic modeling studies.Drug design, development and therapy · 2015Article
- Pharmacokinetic interactions of herbs with cytochrome p450 and p-glycoprotein.Evidence-based complementary and alternative medicine : eCAM · 2015Review
- Identification and evaluation of drug-supplement interactions in Hungarian hospital patients.International journal of clinical pharmacy · 2014Article
- Updates on the clinical evidenced herb-warfarin interactions.Evidence-based complementary and alternative medicine : eCAM · 2014Review
- Herbal medicine: a survey of use in Nigerian presurgical patients booked for ambulatory anaesthesia.BMC complementary and alternative medicine · 2012Article
- Effects of Flos carthami on CYP2D6 and on the Pharmacokinetics of Metoprolol in Rats.Evidence-based complementary and alternative medicine : eCAM · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The concomitant use of conventional and herbal medicines can lead to clinically relevant herb-drug interactions. Clinical risk management offers a systematic approach to minimize the untoward consequences of these interactions by paying attention to: (i) risk identification and assessment; (ii) development and execution of risk reduction strategies; and (iii) evaluation of risk reduction strategies. This paper reviews which steps should be explored or taken in these domains to improve the clinical risk management of adverse herb-drug interactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.